000			02306 a2200589 4500
005			20250515035023.0
264		0	_c20060822
008			200608s 0 0 eng d
022			_a1474-547X
024	7		_a10.1016/S0140-6736(06)69154-X _2doi
040			_aNLM _beng _cNLM
100	1		_aHicks, Charles B
245	0	0	_aDurable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials. _h[electronic resource]
260			_bLancet (London, England) _cAug 2006
300			_a466-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aDrug Resistance, Viral _xgenetics
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEnfuvirtide
650	0	4	_aFemale
650	0	4	_aHIV Envelope Protein gp41 _xtherapeutic use
650	0	4	_aHIV Fusion Inhibitors _xtherapeutic use
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Protease Inhibitors _xadministration & dosage
650	0	4	_aHIV-1 _xgenetics
650	0	4	_aHumans
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMulticenter Studies as Topic
650	0	4	_aPeptide Fragments _xtherapeutic use
650	0	4	_aPyridines _xadministration & dosage
650	0	4	_aPyrones _xadministration & dosage
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRitonavir _xadministration & dosage
650	0	4	_aSulfonamides
650	0	4	_aTime Factors
650	0	4	_aTreatment Failure
650	0	4	_aViral Load
700	1		_aCahn, Pedro
700	1		_aCooper, David A
700	1		_aWalmsley, Sharon L
700	1		_aKatlama, Christine
700	1		_aClotet, Bonaventura
700	1		_aLazzarin, Adriano
700	1		_aJohnson, Margaret A
700	1		_aNeubacher, Dietmar
700	1		_aMayers, Douglas
700	1		_aValdez, Hernan
773	0		_tLancet (London, England) _gvol. 368 _gno. 9534 _gp. 466-75
856	4	0	_uhttps://doi.org/10.1016/S0140-6736(06)69154-X _zAvailable from publisher's website
999			_c16479062 _d16479062